Skip to main content
OpenTrials

Clinical trial condition

Unresectable Melanoma

Explore clinical trials studying Unresectable Melanoma. Study availability and eligibility vary by location and protocol.

52 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Unresectable Melanoma trial results

Recruiting

Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma

NCT05428007

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations
  • The Angeles Clinic at Cedars Sinai Los Angeles, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • NYU Langone Health New York, United States
View Trial Details
Not Yet Recruiting

A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untreated, Unresectable or Metastatic Melanoma Participants In India

NCT07459543

Conditions
Melanoma, Metastatic Melanoma, Neoplasms, +12 more
Locations
  • Local Institution - 0009 Navi Mumbai, Maharashtra, India
  • Local Institution - 0008 Pune, Maharashtra, India
  • Local Institution - 0003 Bhubaneswar, Odisha, India
  • Local Institution - 0002 Chennai, India
View Trial Details
Completed

A Study to Investigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of Treatment

NCT04526899

Conditions
Melanoma, Melanoma Stage III, Melanoma Stage IV, +12 more
Locations
  • University Of Arizona College Of Medicine Tucson, Arizona, United States
  • University of California, San Francisco: Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Sylvester Comprehensive Cancer Center/ UMHC Miami, Florida, United States
  • Oncology Hematology West P.C. dba Nebraska Cancer Specialists Omaha, Nebraska, United States
View all 49 locations
View Trial Details
Completed

Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

NCT01950390

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +12 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
  • Kaiser Permanente-Baldwin Park Baldwin Park, California, United States
View all 482 locations
View Trial Details
Completed

Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer

NCT01902173

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +25 more
Locations
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • California Pacific Medical Center-Pacific Campus San Francisco, California, United States
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
View all 16 locations
View Trial Details

Related conditions